Skip to content
  • Clinical Trials
  • Treatments
  • Indications
  • Publications
  • News
  • Contact

Category: Uncategorized

Media Coverage

Posted on November 7, 2024 by Jan Kubanek

The clinical trial results for treatments of chronic pain and depression using Diadem have been featured in the Washington Post, Circuit News, SciTech Daily, New Atlas, and others. […]

Read More

SPIRE wins the Altitude Lab DEMO day pitch competition

Posted on October 2, 2024 by Jan Kubanek

We are honored to receive this recognition. We are also grateful for the new connections. […]

Read More

Accepting patients onto Phase 3 clinical trials for chronic pain and depression

Posted on August 27, 2024 by admin

The Phase 2 clinical studies are now complete for both indications. We are recruiting patients for Phase 3 studies, so that these treatments obtain regulatory approval and can be administered to patients at a large scale. You can participate through the [clinical trials] tab. […]

Read More

Chronic pain Phase 2 clinical trial complete and published

Posted on August 27, 2024 by admin

These results are now published in PAIN: https://journals.lww.com/pain/fulltext/9900/noninvasive_targeted_modulation_of_pain_circuits.670.aspx This randomized, sham-controlled clinical study found a sustantial, sustained, and safe improvement in pain symptoms. […]

Read More

Recent Posts

  • Media Coverage
  • SPIRE wins the Altitude Lab DEMO day pitch competition
  • SPIRE wins the Wilson Sonsini Entrepreneur & Investor Life Science Summit competition
  • Accepting patients onto Phase 3 clinical trials for chronic pain and depression
  • Chronic pain Phase 2 clinical trial complete and published

Archives

  • October 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  1. Home
  2. Archive by Category "Uncategorized"

SPIRE Therapeutics, Inc.
48 S Rio Grande Street
Salt Lake City UT, 84101-1179

  • Clinical Trials
  • Treatments
  • Indications
  • Publications
  • News
  • Contact

Copyright © 2025 SPIRE